anti-Prx3
Peroxyridoxine-3 inhibits acetaminophen-induced hepatitis B through regulation of mitochondrial ROS.
Pyroptosis is a newly discovered form of cell death. Pyridoxine-3 (PRX3) plays an important role in scavenging reactive oxygen species (ROS), but its ability to protect the liver in acetaminophen-induced liver disease (APAP) remains unclear. The aim of this study was to evaluate the role of PRX3 in the regulation of hepatitis during APAP-mediated hepatotoxicity. We show that in APAP-induced hepatocellular injury, pyroptosis is accompanied by severe oxidative stress and inflammation, and liver-specific PRX3 silencing exacerbated the onset of pH and liver injury after APAP intervention. In particular, excess mitochondrial ROS (mtROS) leading to pH induction through NLRP3 inflammasome activation was observed, which was ameliorated by Mito-TEMPO treatment, indicating that the anti-inflammatory role of PRX3 depends on its strong ability to regulate counters Overall, PRX3 regulates NLRP3-dependent upregulation in APAP-induced liver injury by targeting mitochondrial oxidative stress.
Discovery of spilanthol endoperoxide as a natural redox compound effective against Prx3 infection in mammals and Chlamydia trachomatis.
Chlamydia trachomatis (Ct) is an intracellular bacterial pathogen responsible for a large number of diseases ranging from blindness to pelvic inflammatory disease and cervical cancer. Although this disease is effectively treated with antibiotics, concerns about the development of resistance are driving the need for new, low-cost therapies. Here we report the activity of spilanthol (SPL), a natural compound with proven anti-inflammatory properties, against Ct infection. Using selective mitochondrial protein sulfate imaging probes and complementary assays, we identified an increase in mitochondrial oxidation state by SPL as an underlying mechanism leading to disruption of host cell F-actin cytoskeleton regulation and inhibition of Chlamydial infection. The SPL peroxide product (SPL endoperoxide, SPLE), which is predicted to be the active compound in the cell medium, was chemically synthesized and showed stronger antichlamydial activity. Comparison of the interaction of SPL and SPLE with mammalian peroxyroxins showed the preferred interaction of SPLE with Prx3 and a real lack of interaction of SPL with any of the shortened Prx isoforms examined. Cumulatively, these results support a role for SPL as a prodrug, which is converted to SPLE in the cellular environment, leading to inhibition of Prx3, increased mitochondrial oxidation and disruption of the F-actin network, and inhibition of infection. by CT.
The unique design of Trx2 that interacts with SUMO is critical for manipulating mitochondrial ubiquitination and antioxidant activity.
Mitochondrial thioredoxin 2 (Trx2) is a vital mitochondrial redox protein that is involved in normal protein reduction of thiols and provides electrons to peroxiridoxin 3 (Prx3) for H2O2 removal in the mitochondria. It has been widely reported that deletion of Trx2 in cells or mice generates massive reactive oxygen species (ROS) which have been implicated in many pathological processes. In contrast, it remains to be elucidated how ROS regulates Trx2 processing and activity.
Here we show that excess ROS leads to endothelial cell senescence concomitant with attenuation of Trx2 processing in which Trx2 ubiquitination [i.e., a mitochondrial targeting signal peptide (MTS)] is cleaved to generate a form mature. Mutation analyzes indicate that processing of Trx2 is mediated by processing of mitochondrial peptidase (MPP) and intermediate peptidase (MIP) recognition sites within the MTS. Interestingly, a mutation in the SUMO interaction model (SIM), but not in the catalytic sites within the mature Trx2 protein, completely inhibits Trx2 processing without any effect on targeting of Trx2 to mitochondria. Consistently, chemical inhibition of SUMOylation impairs the protein, whereas agonist SUMOylation enhances Trx2 processing. Furthermore, we identified that the α-MPP subunit is a SUMOylated protein that potentially mediates Trx2 binding and cleavage. Furthermore, the unprocessed form of Trx2-SIM is unable to protect cells from both ROS generation and oxidative stress-induced cellular senescence. antisenescence activities.
Inhibition of apoptosis of Edwardsiella tarda: a strategy for intracellular survival.
Edwardsiella tarda is a Gram-negative bacterial pathogen that can infect a wide variety of freshwater and marine fish. A notable feature of E. tarda is the ability to survive and reproduce in different host cells. In this study, we observed that E. tarda proliferates strongly in the zebrafish cell line ZF4, and that cells infected with E. Global transcriptomic analysis and quantitative real-time RT-PCR revealed that E. infection investigates the role of apoptosis in E. Post-infection study found that overexpression of Fech and Prx3 significantly enhanced proliferation of E. Consistently, when Fech and Prx3 were knocked down in zebrafish, E. These results indicate for the first time that E.
Members of the peroxyrdoxin family (Prx3 and Prx4) and pregnancy disorder (recurrent pregnancy loss).
The placenta is a unique tissue for pregnancy, and the proper formation of the placenta is an exceptional step essential for a successful pregnancy. Peroxyroxins (Prxs) are a family of antioxidant proteins. This family consists of six members, among which peroxyredoxin 3 (Prx3) and peroxyredoxin 4 (Prx4) are expressed in cytotrophoblasts and play an important role in implantation and normal placenta through their antioxidant activities. Although the presence of autoantibodies against various members of the peroxiroxin family has been previously reported, there have been no reports of the presence of autoantibodies against Prx3 or Prx4 in aborted human pregnancies. Therefore, for the first time we hypothesized and pointed out that uncontrolled oxidative stress, due to anti-peroxidoxin antibodies, may impair proper placental formation and lead to placental-related pregnancy disorders such as miscarriage. Our results suggest that two types of placental proteins, Prx3 and Prx4, may function as novel placental immune targets. Given the role of antioxidant defense in protecting the placenta from oxidative stress, the production of antibodies against peroxypyridoxine 3 and 4 may present a new hypothesis of autoimmunity to spontaneous abortion, which should be tested in future works.
anti- PRX3 antibody |
|||
| FNab06838 | FN Test | 100µg | 606.3 EUR |
Paired Family Homeodomain Protein Prx3 (PRX3) Antibody |
|||
| abx236838-100g | Abbexa | 100 µg | 350 EUR |
Paired Family Homeodomain Protein Prx3 (PRX3) Antibody |
|||
| abx236838-100ug | Abbexa | 100 ug | 577.2 EUR |
Prx3 ELISA kit |
|||
| 55R-1871 | Fitzgerald | 1 kit | 891.6 EUR |
Human Prx3 ELISA kit |
|||
| LF-EK0113 | Abfrontier | 1×96T | 723.6 EUR |
Human Prx3 ELISA kit (4X96T) |
|||
| LF-EK0114 | Abfrontier | 4×96T | 2454 EUR |
Human Prx3 ELISA kit (10X96T) |
|||
| LF-EK0115 | Abfrontier | 10×96T | 5380.8 EUR |
anti-Prx3 |
|||
| LF-PA0255 | Abfrontier | 100 ul | 400.8 EUR |
Anti-PRX3 antibody |
|||
| PAab06838 | Lifescience Market | 100 ug | 426 EUR |
anti-Prx3 (1C11) |
|||
| LF-MA0381 | Abfrontier | 100 ul | 400.8 EUR |
anti- PRX5 antibody |
|||
| FNab06839 | FN Test | 100µg | 606.3 EUR |
anti- P2RX4 antibody |
|||
| FNab10076 | FN Test | 100µg | 658.5 EUR |
anti- P2RX7 antibody |
|||
| FNab10078 | FN Test | 100µg | 658.5 EUR |
The thioredoxin reductase inhibitor auranofin drives apoptosis through a Bax/Bak-dependent process involving oxidation of peroxiridoxine 3.
Thioredoxin reductase (TrxR) is an important selenoprotein antioxidant enzyme and a potential target for anticancer drugs. A strong inhibitor of TrxR is the gold(I) compound auranofin, which can trigger mitochondria-dependent apoptotic pathways. The exact mechanism of apoptosis induction by auranofin remains unclear, but there are indications that mitochondrial oxidative stress is a central event. We evaluated the redox state of peroxiridoxine (Prxs) in Jurkat T lymphoma cells treated with auranofin and found that Prx3 mitochondria were more sensitive to oxidation than cytosolic Prx1 and 2, indicating selective mitochondrial stress. Prx3 oxidation was detected at apoptotic doses of auranofin in several cell types and occurred before other mitochondrial events, including cytochrome c release and mitochondrial depolarization. Auranofin was also able to sensitize U937 cells to TNF-alpha apoptosis. Auranofin-induced apoptosis was effectively blocked by Bcl-2 overexpression, and Bax/Bak-deficient mouse embryonic fibroblasts were also resistant to apoptosis, suggesting a central role for proapoptotic proteins of this family in auranofin-induced apoptosis. Auranofin exposure inhibited the proliferation of cells resistant to apoptosis, and at high doses, auranofin could cause necrotic cell death. We conclude that auranofin induces apoptosis in cells through a Bax/Bak-dependent mechanism associated with a selective perturbation of redox homeostasis in mitochondria together with Prx3 oxidation.
